Biology & Biotechnology

Event Profile: Oceanology International is the world's largest marine science and ocean technology exhibition and conference, covering all aspects of the industry - survey, hydrography, remote sensing, navigation, position fixing, environment and coastal protection, diving & underwater services, pollution monitoring & control, leisure, resources, defence and regulation of the sea. Highlights: OI 04 attracted a record audience. 7,003 industry professionals arrived in London over four days to attend the world's premier marine science/ocean technology exhibition & conference, OI London 2004. With a large number of exhibitors reporting contracts signed at the show, and visitors from over 70 countries attending, the latest event has been hailed as one of the best ever, especially for its clear international relevance to the marine science industry. Visitor's Profile: Metocean Specialist, Surveyor, Port Hydrographer, Marine Ecophysiologist, Principal Hydrographic Surveyor, Naval Adviser, Physical Oceanogrpaher, Marine Geophysicist, Hydrographic Systems Manager, Marine Science Advisor, Research Scientist, Senior Geophysicist, Head of Offshore Surveys, Survey Operations manager, Global Survey Manager are the target visitors. Exhibitor's Profile: Profile for exhibit include Acoustics, Climate Change, Dredging & Coastal Engineering, Geosciences, Marine Civil Engineering, Marine Environmental Sciences, Marine GIS Marine Pollution, Marine Renewables, Maritime Defence & Security, Navigation & Remote Sensing, Ocean Observation & Modelling, Oceanography, Subsea Systems, hydrography, environment and coastal protection, diving & underwater services, pollution monitoring & control, defence and regulation of the sea etc. Organizer: Spearhead Exhibitions Limited Oriel House, 26, The Quadrant, Richmond, Surrey, United Kingdom. Tel: +(44)-(20)-84398900 Fax: +(44)-(20)-84398855

Advances in Synthetic Biology 6 to 7 March 2008 Cambridge, United Kingdom Website: http://www.selectbiosciences.com/conferences/ASB2008 Contact name: Elena Cowles Synthetic biology is the design and construction of new biological parts, devices and systems, and the re-design of existing, natural biological systems for useful purposes. Organized by: Selcet Biosciences

INECE is pleased to announce that it will hold its 8th International Conference on 5-11 April 2008 in Cape Town, South Africa. INECE’s triennial international conferences bring together environmental compliance and enforcement practitioners from more than 80 countries and organizations to build partnerships for enforcement cooperation and to share a wide range of skills and experiences that improve compliance with international and domestic environmental laws. The 7th Conference (2005) provided training on INECE's principles of compliance and enforcement course and fostered the development of a new compliance and enforcement network for the Maghreb region. The Conference resulted in the Marrakech Statement and Call to Action on making law work for people, environment, and sustainable development. The 8th Conference will open with two days dedicated to local capacity building and networking events. The subsequent five days will feature action-oriented thematic workshops, distinguished keynote speakers, and networking opportunities for over 150 invited participants, and will include a day for field visits to sites of innovative environmental enforcement initiatives in South Africa. Central themes of the Conference will include "Strategic Management of Environmental Compliance & Enforcement Programs," "Detecting Noncompliance," "Transboundary Compliance," "Biodiversity and Compliance," "Climate Change and Compliance," and "Compliance Promotion and Social Aspects." INECE will be releasing a Call for Papers on these and other environmental compliance and enforcement topics in advance of the Conference. South Africa's Department of Environmental Affairs and Tourism, which is supporting the Conference, noted that "[e]nvironmental compliance and enforcement are becoming high profile issues in South Africa in the context of high economic growth and development, ...the ongoing protection of our biodiversity and protected areas, and the required adaptation for climate change. We therefore welcome the attention that the INECE Conference will bring to environmental compliance and enforcement in South and Southern Africa." Additional information on the 8th Conference, including the Call for Papers, will be made available in the coming months. Conference participation is by invitation only; nominations will be made through the regional compliance and enforcement networks.

Cell and molecular Biology have made tremendous strides over time. Inputs from physical scientists especially in the area of structural biology has added a great deal of information to our knowledge base of interrelationship between structure and function. Structure can be manipulated to modulate a function or create a new function. Today the nature code for man, disease causing parasires, arabidopsis and rice are already accessible. In today's post genomic era proteomes are well analysed thanks to the advent of several kinds of massspectrometers. However, inspite of these advances we have only partial understanding of complex processes like cell growth, cell cycle, cell proliferation, cell differentiation inter- and intra-cellular trafficking and apoptosis. In organismic level growth development and adaptation of organisms to their environment are not well understood. The International Congress on Cellular and Molecular Biology will focus on life processes that are least understood.

A Two-Day Comprehensive & Interactive Course with Workshops on: - FDA's Center for Devices and Radiological Health Investigations - Clarifying FDA Classification of Medical Devices - Memoranda of Understanding (MOU) - Developing QSR/GMP/ISO for combo products - Principals of ICH GCP for Medical Devices - Definitions and Classifications of Medical Device - The Premarket Notification (510K) Summaries and Reviews - Investigational Device Exemption (IDE) Applications - Premarket Approval (PMA) Review Process - Safety and Effectiveness Requirements - Humanitarian Device Exemption (HDE) - Post Market Obligations - Managing Recalls and Problem Reporting - Planning and Implementing an Clinical Audit - Determining a Regulatory Strategy - Clinical Trials for Medical Devices - Sponsor Obligations - Inspection and Audit of Vendors - FDA Notification procedures Distinguished Course Leaders Martha A. Feldman, RAC President & CEO Drug & Device Development Co., Inc. Albert A. Ghignone, MS, RAC CEO AAG Incorporated

Main Topics: Pediatrics, child health, biological anthropology, growth and development, body composition, clinical nutrition, community medicine, cytogenetics and biochemical genetics, dermatology and venereal diseases, disability and mental health, endocrinology and diabetes, environmental health impacts, histopathology, laboratory medicine, molecular and immunogenetics, oro-dental diseases, pharmacology and toxicology, prenatal genetics, reproductive health, gynecology and obstetrics, and free papers in medical sciences. Registration fees: US$ 150 which include: opening ceremony, admission to scientific sessions, admission to technical exhibitions, conference kit, certificate of attendance, coffee and lunch breaks. Accommodation: Accommodation can be arranged on request. Payment: Bank trasfere: National Bank of Egypt, Cairo, Account No. 9/450/81761/1. Email: Nrc_med@yahoo.com Contact person: Prof. Dr. Ashraf Shaalan Head of Medical Research Division National Research Centre Cairo, Egypt.

An Important Two-Day Comprehensive & Interactive Seminar with Case Studies and Workshops On: - FDA, Today and Tomorrow - FDA Rules and Regulations - FDA’s Initiative on Pharmaceutical cGMPs for the 21st Century - Application and Approval in the US - FDA Inspections - FDA Pre-Approval Inspectional Program Before, During and After - System Based Inspections Quality, Facility & Equipment, Materials, Production, Packaging/Labeling, Lab Controls - A Quality Systems Approach to GMPs - Most Common GMP Deficiencies by Systems - Expectations for cGMPs for Laboratories - Inspections of Combination Devices - Requirements for Inspection Preparations - Surviving an US FDA Audit - Criteria for Warning Letter vs Violation Letter - Responding to FDA FD-483 Distinguished Course Leaders Ms. Maxine Fritz Vice President, Pharmaceutical Quality Systems and Validation Quintiles Consulting Mr. John Godshalk Senior Consultant Biologics Consulting Group Dr. Marla Phillips Senior Compliance Consultant

With clinics continually surfacing in retail chain stores across the country, it’s apparent these clinics have delivered what consumers want and are quickly becoming part of a serious industry. Is your organization prepared to harness the success of this rapidly expanding industry?

In this 2nd International Congress on Gait and Mental Function, we will provide delegates with a complete update of this rapidly advancing field. The program will contain a mixture of clinically oriented presentations and the latest scientific highlights, thus providing a mixed menu that should appeal to a broad audience. Specific new elements in this conference include the neuropharmacology behind gait and mental dysfunction; innovative rehabilitation approaches to reduce falls caused by mental dysfunction; and the importance of gait and mental dysfunction in the ageing population. Each plenary session will feature state-of-the-art contributions by internationally recognised experts in their fields

As combinations of drugs from different classes that have synergistic or additive effect and properties to cancel out each others' untoward hemodynamic and metabolic effects become more and more widely used, their use as first-line therapy for the treatment of newly diagnosed hypertensive patients is growing in popularity as well. More and more combinations are coming out on the market and proving their effectiveness in randomized controlled trials and in large multicenter studies. Compliance of patients is of utmost importance in the control of any chronic disease and multiple coexisting disorders. Fixed combinations can facilitate treatment and improve this issue enormously. The advantages of a fixed combination include use of fewer pills with low individual drug doses that will foster better tolerability, convenience, lower cost and thus ensure better compliance. We believe that now is the right time for experts in the fields of internal medicine, cardiology, nephrology, family medicine and primary care physicians to meet and discuss the role of fixed combination in the treatment of hypertension and dyslipidemia in today's medicinal world.